SAN FRANCISCO — Governor Gavin Newsom on Sep 15 highlighted major expansions from Amgen and Gilead Sciences that will bring nearly $1.5 billion in investment, thousands of new jobs and continued momentum to California’s biotech sector. These projects strengthen California’s position as a global leader in life sciences, research and innovation.

Earlier this month, biotechnology leader Amgen announced a $600 million investment to expand its global headquarters in Thousand Oaks with a new research center. The new development will expand their Ventura County-based workforce of 5,500 and bring together researchers, engineers and scientists from across disciplines to advance the next era of scientific discovery and human health.

In the same week, biopharmaceutical giant Gilead Sciences broke ground on a new pharmaceutical development and manufacturing center as part of its broader $847 million investment to expand its Foster City campus. Once complete in 2029, these new facilities are anticipated to support nearly 2,500 jobs, contribute $227 million in annual GDP and strengthen the region’s role as a leader in biotechnology.